Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Head & Neck 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Breast Neoplasms 1Anus Neoplasms 1

Interventions

Cetuximab 4pembrolizumab 3Trastuzumab 3Radiotherapy 3Erlotinib Hydrochloride 3Tomography, X-Ray Computed 2Magnetic Resonance Spectroscopy 2Fluorodeoxyglucose F18 2Docetaxel 2Biopsy 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1sargramostim 1sapanisertib 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1oblimersen 1nanocis 1mercaptoundecahydrododecaborate 1larotrectinib 1ipatasertib 1fluoromisonidazole 1erythromycin propionate-N-acetylcysteinate 1erdafitinib 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Diphenhydramine × Head & Neck × Clear all
NCT04432597 2026-05-18

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
39 enrolled
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡